1. Home
  2. RAPT vs RBKB Comparison

RAPT vs RBKB Comparison

Compare RAPT & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • RBKB
  • Stock Information
  • Founded
  • RAPT 2015
  • RBKB 1860
  • Country
  • RAPT United States
  • RBKB United States
  • Employees
  • RAPT N/A
  • RBKB N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • RBKB Banks
  • Sector
  • RAPT Health Care
  • RBKB Finance
  • Exchange
  • RAPT Nasdaq
  • RBKB Nasdaq
  • Market Cap
  • RAPT 117.5M
  • RBKB 111.3M
  • IPO Year
  • RAPT 2019
  • RBKB 2019
  • Fundamental
  • Price
  • RAPT $0.75
  • RBKB $11.18
  • Analyst Decision
  • RAPT Hold
  • RBKB
  • Analyst Count
  • RAPT 7
  • RBKB 0
  • Target Price
  • RAPT $5.00
  • RBKB N/A
  • AVG Volume (30 Days)
  • RAPT 829.4K
  • RBKB 9.3K
  • Earning Date
  • RAPT 05-08-2025
  • RBKB 04-24-2025
  • Dividend Yield
  • RAPT N/A
  • RBKB N/A
  • EPS Growth
  • RAPT N/A
  • RBKB N/A
  • EPS
  • RAPT N/A
  • RBKB N/A
  • Revenue
  • RAPT N/A
  • RBKB $25,911,000.00
  • Revenue This Year
  • RAPT N/A
  • RBKB N/A
  • Revenue Next Year
  • RAPT N/A
  • RBKB N/A
  • P/E Ratio
  • RAPT N/A
  • RBKB N/A
  • Revenue Growth
  • RAPT N/A
  • RBKB N/A
  • 52 Week Low
  • RAPT $0.75
  • RBKB $7.30
  • 52 Week High
  • RAPT $8.58
  • RBKB $11.53
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 33.73
  • RBKB 65.58
  • Support Level
  • RAPT $0.75
  • RBKB $11.00
  • Resistance Level
  • RAPT $0.85
  • RBKB $11.53
  • Average True Range (ATR)
  • RAPT 0.08
  • RBKB 0.24
  • MACD
  • RAPT -0.00
  • RBKB 0.08
  • Stochastic Oscillator
  • RAPT 0.97
  • RBKB 76.51

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one- to four-family residential real estate loans, and to purchase investment securities.

Share on Social Networks: